)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Meiji
Meiji (2269) investor relations material
Meiji Q1 2027 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2027 earnings summary5 Aug, 2026
Executive summary
Q1 FY2026 consolidated operating profit rose to JPY 22.7 billion, up 27.7% year-over-year, with significant profit increases in both Food and Pharmaceutical segments.
Net sales rose 5.8% year-over-year to JPY 289.4 billion, with profit attributable to owners of parent up 51.3%.
Comprehensive income nearly doubled year-over-year, reflecting strong operational performance.
Structural reforms advanced in Japan and overseas, including business transfers and plant closures.
Financial highlights
Operating profit margin improved to 7.8% from 6.5% year-over-year.
Ordinary profit was JPY 24.8 billion, up 37.8% year-over-year.
Profit attributable to owners of parent increased 51.3% to JPY 15.3 billion.
EPS rose to JPY 56.33 from JPY 37.27 year-over-year.
Gross profit margin improved, with gross profit up 11.1% year-over-year.
Outlook and guidance
Full-year net sales forecast at JPY 1,212.0 billion (+3.3% year-over-year), with operating profit projected at JPY 100.0 billion (+9.9%).
Profit attributable to owners of parent expected to reach JPY 62.5 billion (+78.2%), with EPS forecast at JPY 230.61.
No revisions to H1 or full-year guidance.
Dividend payout ratio for FY2026 forecast at 81.1%.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Meiji
- Sales and operating profit rose, but net profit fell as a growth-focused plan targets recovery.2269
Q4 2024 - FY 2025 profit beat plan on pharma strength; FY 2026/2027 targets growth and ROE recovery.2269Q4 2026
- Impairment in China drives restructuring, with renewed focus on growth, ROE, and innovation.2269Investor presentation
- Operating profit rose on Food segment strength, but net profit fell on higher costs and impairment.2269Q3 2026
- Operating profit beat plan, but sales forecast lowered amid cost pressures and reforms.2269Q2 2026
- Profits declined in Q1, but full-year outlook and dividend plans remain strong.2269Q1 2026
- Pharmaceuticals drove profit growth as food margins fell; full-year outlook and share cancellation steady.2269Q2 2025
- Sales and profit rose, led by pharmaceuticals, despite food margin pressures.2269Q1 2025
- Sales and profit growth continue, with higher dividends and strategic investments ahead.2269Q4 2025
Next Meiji earnings date
Q2 202712 Nov, 2026
Meiji
Next Meiji earnings date
Q2 202712 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Meiji Holdings Co., Ltd. is a Japan-based company engaged in the production and sale of food and pharmaceutical products. Through its subsidiaries, the company operates in two main segments: Food and Pharmaceuticals. The Food segment offers dairy products, confectionery, and nutritionals, including milk, yogurt, chocolate, and infant formula. The Pharmaceuticals segment focuses on the development and manufacturing of prescription drugs, vaccines, and over-the-counter healthcare products. The company is headquartered in Tokyo, Japan, and its shares are listed on the TSE.